Rainbow Children's Medicare Ltd

Rainbow Children's Medicare Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. The report, prepared on a consolidated basis, includes an Independent Practitioners' Reasonable Assurance Report on BRSR Core Indicators by M/s. Adwin Advisory Private Limited. The company's operations are primarily in human health activities, accounting for 100% of its turnover, with healthcare services being its main product. As of FY26, the company operates 23 hospitals and 5 clinics across 6 states in India, employing a total of 6,397 individuals, with women constituting 62% of the workforce. The company also reported 2 differently-abled employees.

Rainbow Children's Medicare Ltd has informed the stock exchanges about the dispatch of a letter containing a QR code and web-link to access its Integrated Annual Report for the Financial Year 2025-26. This report has been emailed to shareholders with registered email addresses and sent via letter to those whose emails are not registered. The company is complying with SEBI Listing Regulations regarding the dissemination of the annual report.

Rainbow Children's Medicare Ltd has filed its Integrated Annual Report for the Financial Year 2025-26. The report, prepared in accordance with SEBI Listing Regulations and other applicable laws, provides a comprehensive view of the company's financial performance, operational progress, clinical excellence, and societal contribution. It details the company's strategic imperatives, business model, risk management, and value creation across six capitals: Financial, Manufactured, Intellectual, Human, Social and Relationship, and Natural. The report is available on the company's website and has been sent electronically to registered members.

Rainbow Children's Medicare Ltd has announced its 28th Annual General Meeting (AGM) will be held on Wednesday, July 29, 2026, at 10:00 AM IST. The meeting will be conducted through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company is also submitting its Integrated Annual Report for the Financial Year 2025-26, which includes the AGM notice. This report, sent electronically to registered members, is also available on the company's website. The report covers financial performance, operational progress, clinical excellence, and societal contributions, structured around six capitals: Financial, Manufactured, Human, Intellectual, Social and Relationship, and Natural.

Rainbow Children's Medicare Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. The decision aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code for preventing insider trading. All designated persons and their immediate relatives are restricted from trading during this period.

Rainbow Children's Medicare Ltd's board approved the audited standalone and consolidated financial results for the year ended March 31, 2026. They recommended a final dividend of ₹3.5 per equity share (35% on face value of ₹10), subject to shareholder approval at the AGM on July 29, 2026. The board also approved the re-appointment of Dr. Ramesh Kancharla and Dr. Dinesh Kumar Chirla as Chairman & Managing Director and Whole Time Director, respectively, for five years, and Mr. Santanu Mukherjee as an Independent Director for a second term, all subject to shareholder approval.

Rainbow Children's Medicare Ltd's board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. They recommended a final dividend of ₹3.5 per equity share (35%) subject to shareholder approval at the AGM scheduled for July 29, 2026. The record date for the dividend and AGM is set for July 21, 2026. The board also approved the re-appointment of Dr. Ramesh Kancharla and Dr. Dinesh Kumar Chirla as Chairman & MD and Whole Time Director, respectively, and Mr. Santanu Mukherjee as an Independent Director, all for five-year terms, subject to shareholder approval.

Rainbow Children's Medicare Ltd has re-appointed M/s. Lavanya & Associates as the Cost Auditors for the financial year 2026-27. The Board of Directors also approved the audited financial results for the year ended March 31, 2026, recommended a final dividend of ₹ 3.5 per share, and approved the re-appointment of Dr. Ramesh Kancharla, Dr. Dinesh Kumar Chirla and Mr. Santanu Mukherjee, subject to shareholder approval at the upcoming AGM.

Rainbow Children's Medicare Ltd's board re-appointed Mr. Santanu Mukherjee as an Independent Director for a second term of five years, from October 22, 2026, to October 21, 2031, subject to shareholder approval at the upcoming Annual General Meeting. The board also approved the re-appointment of Dr. Ramesh Kancharla as Chairman and Managing Director and Dr. Dinesh Kumar Chirla as Whole Time Director, each for five-year terms.

Rainbow Children's Medicare Ltd's Board of Directors has approved the re-appointment of Dr. Ramesh Kancharla as Chairman and Managing Director for five years, from August 11, 2026, to August 10, 2031, subject to shareholder approval. The board also approved the re-appointment of Dr. Dinesh Kumar Chirla as Whole Time Director for a similar term, and Mr. Santanu Mukherjee as an Independent Director for a second term of five years. The board recommended a final dividend of ₹3.5 per equity share and fixed July 21, 2026, as the record date for the dividend and AGM.